146 related articles for article (PubMed ID: 37468827)
1. Selection of Silica Type and Amount for Flowability Enhancements via Dry Coating: Contact Mechanics Based Predictive Approach.
Kunnath KT; Tripathi S; Kim SS; Chen L; Zheng K; Davé RN
Pharm Res; 2023 Dec; 40(12):2917-2933. PubMed ID: 37468827
[TBL] [Abstract][Full Text] [Related]
2. Decoding Fine API Agglomeration as a Key Indicator of Powder Flowability and Dissolution: Impact of Particle Engineering.
Kim S; Cheikhali M; Davé RN
Pharm Res; 2022 Dec; 39(12):3079-3098. PubMed ID: 35698012
[TBL] [Abstract][Full Text] [Related]
3. Impact of Silica Dry Coprocessing with API and Blend Mixing Time on Blend Flowability and Drug Content Uniformity.
Kim SS; Seetahal A; Amores N; Kossor C; Davé RN
J Pharm Sci; 2023 Aug; 112(8):2124-2136. PubMed ID: 37230252
[TBL] [Abstract][Full Text] [Related]
4. Improving blend content uniformity via dry particle coating of micronized drug powders.
Huang Z; Xiong W; Kunnath K; Bhaumik S; Davé RN
Eur J Pharm Sci; 2017 Jun; 104():344-355. PubMed ID: 28435077
[TBL] [Abstract][Full Text] [Related]
5. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
[TBL] [Abstract][Full Text] [Related]
6. Enhanced blend uniformity and flowability of low drug loaded fine API blends via dry coating: The effect of mixing time and excipient size.
Kim SS; Castillo C; Cheikhali M; Darweesh H; Kossor C; Davé RN
Int J Pharm; 2023 Mar; 635():122722. PubMed ID: 36796658
[TBL] [Abstract][Full Text] [Related]
7. Reduced Fine API Agglomeration After Dry Coating for Enhanced Blend Uniformity and Processability of Low Drug Loaded Blends.
Kim SS; Castillo C; Sayedahmed M; Davé RN
Pharm Res; 2022 Dec; 39(12):3155-3174. PubMed ID: 35882741
[TBL] [Abstract][Full Text] [Related]
8. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
Kunnath K; Huang Z; Chen L; Zheng K; Davé R
Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
[TBL] [Abstract][Full Text] [Related]
9. Influence of coating material on the flowability and dissolution of dry-coated fine ibuprofen powders.
Qu L; Zhou QT; Denman JA; Stewart PJ; Hapgood KP; Morton DA
Eur J Pharm Sci; 2015 Oct; 78():264-72. PubMed ID: 26215464
[TBL] [Abstract][Full Text] [Related]
10. Surface engineered excipients: II. Simultaneous milling and dry coating for preparation of fine-grade microcrystalline cellulose with enhanced properties.
Chen L; Ding X; He Z; Fan S; Kunnath KT; Zheng K; Davé RN
Int J Pharm; 2018 Jul; 546(1-2):125-136. PubMed ID: 29763689
[TBL] [Abstract][Full Text] [Related]
11. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
Huang Z; Scicolone JV; Han X; Davé RN
Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
[TBL] [Abstract][Full Text] [Related]
12. Profoundly improving flow properties of a cohesive cellulose powder by surface coating with nano-silica through comilling.
Chattoraj S; Shi L; Sun CC
J Pharm Sci; 2011 Nov; 100(11):4943-52. PubMed ID: 21698602
[TBL] [Abstract][Full Text] [Related]
13. Impact of dry coating lactose as a brittle excipient on multi-component blend processability.
Lin Z; Cabello B; Davé RN
Int J Pharm; 2024 Mar; 653():123921. PubMed ID: 38382769
[TBL] [Abstract][Full Text] [Related]
14. Facilitating direct compaction tableting of fine cohesive APIs using dry coated fine excipients: Effect of the excipient size and amount of coated silica.
Lin Z; Cabello B; Kossor C; Davé R
Int J Pharm; 2024 Jun; 660():124359. PubMed ID: 38901539
[TBL] [Abstract][Full Text] [Related]
15. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
[TBL] [Abstract][Full Text] [Related]
16. On the relationship of inter-particle cohesiveness and bulk powder behavior: Flowability of pharmaceutical powders.
Capece M; Silva KR; Sunkara D; Strong J; Gao P
Int J Pharm; 2016 Sep; 511(1):178-189. PubMed ID: 27353729
[TBL] [Abstract][Full Text] [Related]
17. Impact of altered hydrophobicity and reduced agglomeration on dissolution of micronized poorly water-soluble drug powders after dry coating.
Kim S; Bilgili E; Davé RN
Int J Pharm; 2021 Sep; 606():120853. PubMed ID: 34252519
[TBL] [Abstract][Full Text] [Related]
18. Effects of Coating Materials and Processing Conditions on Flow Enhancement of Cohesive Acetaminophen Powders by High-Shear Processing With Pharmaceutical Lubricants.
Wei G; Mangal S; Denman J; Gengenbach T; Lee Bonar K; Khan RI; Qu L; Li T; Zhou QT
J Pharm Sci; 2017 Oct; 106(10):3022-3032. PubMed ID: 28551425
[TBL] [Abstract][Full Text] [Related]
19. [Research about improving flowability of powder of Chinese herbs extracts by surface modification technology].
Yu YH; Lu WL; Li JJ; Sun CC; Zhou Q
Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4590-5. PubMed ID: 25911807
[TBL] [Abstract][Full Text] [Related]
20. Passivation of high-surface-energy sites of milled ibuprofen crystals via dry coating for reduced cohesion and improved flowability.
Han X; Jallo L; To D; Ghoroi C; Davé R
J Pharm Sci; 2013 Jul; 102(7):2282-96. PubMed ID: 23658057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
